A soluble form of CD80 enhances antitumor immunity by neutralizing programmed death ligand-1 and simultaneously providing costimulation

Cancer immunology research

Volumn 2, Issue 7, 2014, Pages 610-615

  Haile, Samuel T ^a   Horn, Lucas A ^a   Ostrand Rosenberg, Suzanne ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1;

ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DEFICIENCY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MELANOMA; T LYMPHOCYTE; TUMOR CELL CULTURE; TUMOR ESCAPE;

ANIMALS; ANTIGENS, CD274; ANTIGENS, CD28; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MELANOMA; MICE, INBRED C57BL; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

EID: 84964314377     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0204     Document Type: Article

References (0)